Clinical Trial

Golidocitinib Combined With Selinexor for CAEBVD

Name: Golidocitinib Combined With Selinexor for CAEBVD — clinical trial record (NCT07369739)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

This study is a multicenter, prospective, single-arm clinical investigation, with patients with CAEBVD as the main research subjects, to evaluate the effectiveness of the combined treatment regimen of golidocitinib and selinexor.

Trial Details

NCT Number	NCT07369739
Lead Sponsor	Beijing Friendship Hospital
Conditions	Lymphohistiocytosis, EBV, CAEBV
Enrollment	28 participants
Start Date	2026-01-01
Primary Completion	2027-01-01 (estimated)
Study Completion	2028-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-01-27